The newly approved SGLT2 inhibitor, bexagliflozin, is marketed under the name Brenzavvy. It is not recommended for patients with type 1 diabetes. 

Researchers examined data from nearly 2 million patients, sharing their full findings in JACC: Cardiovascular Imaging.

The topic was explored at length in a new scientific statement presented at the 59th Annual Meeting of the Society of Thoracic Surgeons.

"The singular message to the public is that the optimal treatment for multivessel coronary artery disease—to improve not only long-term survival but also lower your risk of complications—is coronary artery bypass surgery," one specialist said in a statement. 

Even if symptoms disappear quickly, a transient ischemic attack can be a major short-term risk indicator.

Early mortality specifically related to complications during the TLR procedure was quite rare. 

The randomized trial, expected to enroll at least 550 patients, will follow patients for a total of five years.

A recent roundtable discussion focused on how today's healthcare leaders can "begin to dismantle the systems that perpetuate inequities in medicine and build new systems that promote diversity, equity and inclusive excellence."

The "vortex ultrasound" technique eliminates blood clots with helical ultrasound waves, rather than forward-facing waves.  

A 40-year-old man was accompanying his mother to her MRI exam when the magnet caused his gun to fire, shooting him in the abdomen.